NCT07417800
- Conditions
- Adenocarcinoma, Adjuvant Chemoradiotherapy, Artificial Intelligent, +14 more
- Locations
-
- the Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Clinical trial condition
Lenvatinib
Explore clinical trials studying Lenvatinib. Study availability and eligibility vary by location and protocol.
19 public trials
10 recruiting studies
Lenvatinib trial results
NCT06740370
- Conditions
- Adenocarcinoma, Anti-PD1 Antibody, Carcinoma, +12 more
- Locations
-
- Qunfang Zhou Beijing, None Selected, China
NCT05920863
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- 1# Banshan East Rd. Zhejiang cancer hospital Hangzhou, Zhejiang, China
Recruiting
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
NCT06333561
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Chinese PLA General hospital Beijing, Beijing Municipality, China
NCT06609850
- Conditions
- Ablation, Adenocarcinoma, Carcinoma, +13 more
- Locations
-
- Chinese PLA General hospital Beijing, None Selected, China
NCT06632093
- Conditions
- BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Hepatic Arterial Infusion Chemotherapy, +3 more
- Locations
-
- The first hospital of China medical university Shenyang, Liaoning, China
NCT06061276
- Conditions
- Adenocarcinoma, Camrelizumab, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
NCT06550921
- Conditions
- Ablation, Advanced Hepatocellular Carcinoma, Anti-PD1 Antibody, +2 more
- Locations
-
- Chinese PLA General hospital Beijing, None Selected, China
Recruiting
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
NCT06070636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Hunan Provincial People's Hospital Changsha, Hunan, China